NASDAQ : POM
Pomdoctor Limited — Financial statements
Healthcare · Medical Care Facilities · China
Last price 1.99 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.53M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Pomdoctor Limited (POM) reported revenue of 410.45M CNY (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in CNY.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 410.45M | 399.91M | 342.56M | 304.85M | 245.22M | 215.38M |
| Cost of Revenue | 361.21M | 347.63M | 294.86M | 266.13M | 190.36M | 162.88M |
| Gross Profit | 49.24M | 52.28M | 47.69M | 38.72M | 54.86M | 52.51M |
| Selling, General & Admin | 269.56M | 155.94M | 68.24M | 55.99M | 54.87M | 102.95M |
| Research & Development | 117.66M | 12.86M | 3.00M | 3.37M | 3.59M | 4.28M |
| Operating Expenses | 387.22M | 168.81M | 71.25M | 59.36M | 58.46M | 107.23M |
| Operating Income | -337.98M | -116.53M | -23.55M | -20.64M | -3.59M | -54.73M |
| Interest Expense | -12.54M | -12.89M | -12.96M | -13.85M | -16.02M | -16.29M |
| Other Non Operating Income (Expenses) | 1.89M | 588.40K | 1.39M | -851.40K | -214.38K | -223.47K |
| EBT Excluding Unusual Items | -348.63M | -128.82M | -35.13M | -35.34M | -19.83M | -71.24M |
| Gain (Loss) on Sale of Investments | -500.00K | |||||
| Asset Writedown | -523.74K | -2.11M | -2.24M | -1.11M | -24.94M | |
| Other Unusual Items | -29.24M | -81.65M | -105.97M | -108.44M | -105.68M | -92.24M |
| Pretax Income | -378.39M | -212.58M | -143.34M | -145.39M | -125.51M | -188.42M |
| Income Tax Expense | 67.51K | 375.00 | ||||
| Earnings From Continuing Operations | -378.46M | -212.58M | -143.34M | -145.39M | -125.51M | -188.42M |
| Minority Interest in Earnings | 8.39M | 1.52K | -25.88K | -1.06K | 1.88K | 15.27K |
| Net Income | -370.07M | -212.58M | -143.36M | -145.39M | -125.51M | -188.40M |
| Net Income to Common | -370.07M | -212.58M | -143.36M | -145.39M | -125.51M | -188.40M |
| Shares Outstanding (Basic) | 1.81M | 968.06K | 631.02K | 631.02K | 404.20K | 404.20K |
| Shares Outstanding (Diluted) | 1.81M | 968.06K | 631.02K | 631.02K | 404.20K | 404.20K |
| EPS (Basic) | -204.27 | -219.59 | -227.19 | -230.41 | -310.51 | -466.11 |
| EPS (Diluted) | -204.27 | -219.60 | -227.20 | -230.41 | -310.51 | -466.11 |
| Free Cash Flow | -124.84M | -150.09M | -16.17M | -45.91M | -22.02M | -15.68M |
| Free Cash Flow Per Share | -68.91 | -155.04 | -25.62 | -72.75 | -54.47 | -38.80 |
| Gross Margin | 12.00% | 13.07% | 13.92% | 12.70% | 22.37% | 24.38% |
| Operating Margin | -82.35% | -29.14% | -6.88% | -6.77% | -1.47% | -25.41% |
| Profit Margin | -90.16% | -53.16% | -41.85% | -47.69% | -51.18% | -87.47% |
| Free Cash Flow Margin | -30.42% | -37.53% | -4.72% | -15.06% | -8.98% | -7.28% |
| EBITDA | -337.78M | -116.38M | -23.42M | -20.53M | 14.08M | -37.05M |
| EBITDA Margin | -82.30% | -29.10% | -6.84% | -6.73% | 5.74% | -17.20% |
| D&A For EBITDA | 208.69K | 149.31K | 134.51K | 112.09K | 17.68M | 17.68M |
| EBIT | -337.98M | -116.53M | -23.55M | -20.64M | -3.59M | -54.73M |
| EBIT Margin | -82.35% | -29.14% | -6.88% | -6.77% | -1.47% | -25.41% |
| Revenue as Reported | 410.45M | 399.91M | 342.56M | 304.85M | 245.22M | |
| Advertising Expenses | 19.54M | 11.10M | 3.43M | 1.37M | 7.29M |
Balance sheet
Fiscal year January - December; amounts in CNY.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 12.61M | 9.58M | 7.65M | 6.72M | 2.49M | 2.17M |
| Cash & Short-Term Investments | 12.61M | 9.58M | 7.65M | 6.72M | 2.49M | 2.17M |
| Accounts Receivable | 44.69M | 19.27M | 8.80M | 28.64M | 28.27M | 2.18M |
| Other Receivables | 656.23K | 622.00K | 538.14K | 463.81K | 426.58K | 3.10M |
| Receivables | 45.34M | 19.89M | 9.34M | 29.11M | 28.70M | 5.27M |
| Inventory | 5.66M | 8.28M | 9.17M | 12.69M | 8.20M | 8.12M |
| Prepaid Expenses | 1.21M | 1.31M | 837.89K | 582.55K | 417.07K | |
| Restricted Cash | 88.07K | 159.90K | ||||
| Other Current Assets | 8.92M | 65.90M | 10.50M | 10.23M | 7.78M | 2.87M |
| Total Current Assets | 73.74M | 104.97M | 37.50M | 59.42M | 47.74M | 18.43M |
| Property, Plant & Equipment | 880.24K | 1.25M | 461.36K | 595.87K | ||
| Long-Term Investments | 500.00K | 500.00K | ||||
| Long-Term Deferred Charges | 7.44M | 5.74M | ||||
| Other Long-Term Assets | 1.50M | 1.34M | 831.13K | 549.50K | 377.63K | 377.63K |
| Total Assets | 76.12M | 107.56M | 46.23M | 66.31M | 48.62M | 19.31M |
| Accounts Payable | 35.14M | 44.82M | 25.35M | 41.69M | 43.35M | 30.41M |
| Accrued Expenses | 83.13M | 74.54M | 62.65M | 63.28M | 57.63M | 23.58M |
| Short-Term Debt | 65.20M | 68.81M | 60.33M | 45.11M | 29.07M | 22.36M |
| Current Portion of Long-Term Debt | 11.69M | 13.90M | 12.62M | 10.41M | 377.57K | 1.02M |
| Current Portion of Leases | 1.88M | 1.55M | 1.39M | 1.16M | 1.42M | 2.43M |
| Current Unearned Revenue | 931.97K | 1.59M | 1.76M | 1.24M | 2.73M | 1.46M |
| Other Current Liabilities | 12.93M | 12.96M | 15.05M | 9.11M | 9.03M | 28.14M |
| Total Current Liabilities | 210.91M | 218.17M | 179.15M | 172.00M | 143.61M | 109.39M |
| Long-Term Debt | 370.55M | 369.39M | 365.09M | 355.84M | 328.93M | 312.51M |
| Long-Term Leases | 804.10K | 1.29M | 1.67M | 781.26K | 1.44M | 2.94M |
| Total Liabilities | 582.26M | 588.85M | 545.91M | 528.62M | 473.98M | 424.84M |
| Common Stock | 16.41K | 16.41K | 4.40K | 4.40K | 2.79K | 2.79K |
| Additional Paid-In Capital | 2.24B | 2.02B | ||||
| Retained Earnings | -2.71B | -2.48B | -2.26B | -2.12B | -1.97B | -1.85B |
| Comprehensive Income & Other | -4.08M | -1.75M | -6.84K | -1.61K | ||
| Total Common Equity | -470.43M | -453.97M | -2.26B | -2.12B | -1.97B | -1.85B |
| Minority Interest | -35.71M | -27.33M | 168.69M | 158.64M | 76.66M | 71.66M |
| Shareholders' Equity | -506.14M | -481.30M | -499.68M | -462.31M | -425.36M | -405.53M |
| Total Liabilities & Equity | 76.12M | 107.56M | 46.23M | 66.31M | 48.62M | 19.31M |
| Total Debt | 450.13M | 454.94M | 441.10M | 413.29M | 361.24M | 341.26M |
| Net Cash (Debt) | -437.52M | -445.36M | -433.45M | -406.58M | -358.76M | -339.09M |
| Net Cash Per Share | -241.50 | -460.05 | -686.91 | -644.32 | -887.56 | -838.90 |
| Filing Date Shares Outstanding | 2.32M | 2.24M | 631.02K | 4.04M | 4.04M | 404.20K |
| Total Common Shares Outstanding | 2.32M | 2.32M | 631.02K | 4.04M | 4.04M | 404.20K |
| Working Capital | -137.17M | -113.20M | -141.65M | -112.58M | -95.87M | -90.96M |
| Book Value Per Share | -202.92 | -195.82 | -3,586.93 | -524.50 | -488.53 | -4,574.81 |
| Tangible Book Value | -470.43M | -453.97M | -2.26B | -2.12B | -1.97B | -1.85B |
| Tangible Book Value Per Share | -202.92 | -195.82 | -3,586.93 | -524.50 | -488.53 | -4,574.81 |
| Machinery | 6.80M | 7.37M | 6.52M | 6.53M | 5.86M | |
| Leasehold Improvements | 4.76M | 4.76M | 4.76M | 4.76M | 4.85M |
Cash flow statement
Fiscal year January - December; amounts in CNY.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -370.07M | -212.58M | -143.36M | -145.39M | -125.51M | -188.40M |
| Depreciation & Amortization | 208.69K | 149.31K | 134.51K | 112.09K | 21.32M | |
| Loss (Gain) From Sale of Assets | 54.29K | -3.89K | ||||
| Asset Writedown & Restructuring Costs | 523.74K | 2.11M | 2.24M | 1.11M | 24.94M | |
| Loss (Gain) From Sale of Investments | 500.00K | |||||
| Stock-Based Compensation | 232.07M | 16.42M | ||||
| Provision & Write-off of Bad Debts | 474.47K | -240.98K | 841.68K | 1.49M | -774.45K | -894.77K |
| Other Operating Activities | 24.14M | 83.53M | 106.49M | 108.94M | 105.68M | 92.22M |
| Change in Accounts Receivable | -38.13M | -10.51M | 19.89M | -1.27M | -26.10M | -1.76M |
| Change in Inventory | -275.67K | -747.84K | 4.98M | -5.06M | -1.31M | -2.23M |
| Change in Accounts Payable | 9.96M | 19.47M | -16.34M | -1.66M | 12.94M | 5.43M |
| Change in Unearned Revenue | -10.76K | -164.91K | 512.62K | -1.49M | 1.28M | 1.45M |
| Change in Other Net Operating Assets | 17.64M | -45.93M | 8.49M | -3.08M | 11.78M | 32.25M |
| Operating Cash Flow | -123.42M | -148.48M | -16.13M | -45.80M | -22.02M | -15.68M |
| Capital Expenditures | -1.43M | -1.61M | -37.77K | -111.89K | ||
| Sale of Property, Plant & Equipment | 270.00K | 4.40K | ||||
| Investment in Securities | -500.00K | |||||
| Investing Cash Flow | -1.16M | -1.61M | -33.37K | -111.89K | -500.00K | |
| Short-Term Debt Issued | 56.00M | 44.10M | 28.00M | 10.10M | 9.00M | |
| Long-Term Debt Issued | 34.73M | 41.16M | 108.55M | 25.33M | 54.42M | |
| Total Debt Issued | 79.00M | 90.73M | 85.26M | 136.55M | 35.43M | 63.42M |
| Short-Term Debt Repaid | -37.96M | -31.14M | -15.66M | -1.52M | -17.86M | |
| Long-Term Debt Repaid | -38.71M | -37.10M | -68.55M | -11.41M | -40.13M | |
| Total Debt Repaid | -83.45M | -76.67M | -68.24M | -84.21M | -12.94M | -57.99M |
| Net Debt Issued (Repaid) | -4.45M | 14.06M | 17.02M | 52.34M | 22.49M | 5.44M |
| Issuance of Common Stock | 163.93M | 163.93M | ||||
| Other Financing Activities | -23.81M | -24.06M | -2.28M | |||
| Financing Cash Flow | 135.68M | 153.93M | 17.02M | 50.07M | 22.49M | 5.44M |
| Foreign Exchange Rate Adjustments | -4.24M | -1.91M | -5.23K | |||
| Net Cash Flow | 6.86M | 1.93M | 846.60K | 4.16M | 474.66K | -10.74M |
| Free Cash Flow | -124.84M | -150.09M | -16.17M | -45.91M | -22.02M | -15.68M |
| Free Cash Flow Margin | -30.42% | -37.53% | -4.72% | -15.06% | -8.98% | -7.28% |
| Free Cash Flow Per Share | -68.91 | -155.04 | -25.62 | -72.75 | -54.47 | -38.80 |
| Levered Free Cash Flow | 4.10M | -102.35M | -10.39M | -26.42M | -12.10M | -215.05M |
| Unlevered Free Cash Flow | 11.94M | -94.29M | -2.29M | -17.76M | -2.08M | -204.87M |
| Cash Interest Paid | 3.01M | 2.70M | 2.74M | 2.39M | 3.24M | 4.05M |
| Change in Working Capital | -10.82M | -37.87M | 17.53M | -12.56M | -1.41M | 35.14M |
Ratios
Fiscal year January - December; amounts in CNY.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Debt / Equity Ratio | -0.89 | -0.94 | -0.88 | -0.89 | -0.85 | -0.84 |
| Debt / EBITDA Ratio | 20.38 | |||||
| Net Debt / Equity Ratio | -0.86 | -0.93 | -0.87 | -0.88 | -0.84 | -0.84 |
| Net Debt / EBITDA Ratio | -1.29 | -3.83 | -18.51 | -19.80 | 25.48 | -9.15 |
| Net Debt / FCF Ratio | -3.50 | -2.97 | -26.81 | -8.86 | -16.29 | -21.62 |
| Asset Turnover | 6.84 | 5.20 | 6.09 | 5.30 | 7.22 | 4.45 |
| Inventory Turnover | 59.66 | 39.85 | 26.98 | 25.48 | 23.34 | 22.25 |
| Quick Ratio | 0.28 | 0.14 | 0.10 | 0.21 | 0.22 | 0.07 |
| Current Ratio | 0.35 | 0.48 | 0.21 | 0.34 | 0.33 | 0.17 |
| Return on Assets (ROA) | -352.09% | -94.72% | -26.16% | -22.45% | -6.61% | -70.68% |
| Return on Capital Employed (ROCE) | 250.80% | 105.30% | 17.70% | 19.50% | 3.80% | 60.80% |
| Buyback Yield / Dilution | -143.37% | -53.41% | -56.11% | 76.35% |